Defining the Syrian hamster as a highly susceptible preclinical model for SARS-CoV-2 infection

Following emergence in late 2019, SARS-CoV-2 rapidly became pandemic and is presently responsible for millions of infections and hundreds of thousands of deaths worldwide. There is currently no approved vaccine to halt the spread of SARS-CoV-2 and only very few treatment options are available to man...

Full description

Saved in:
Bibliographic Details
Published inEmerging microbes & infections Vol. 9; no. 1; pp. 2673 - 2684
Main Authors Rosenke, Kyle, Meade-White, Kimberly, Letko, Michael, Clancy, Chad, Hansen, Frederick, Liu, Yanan, Okumura, Atsushi, Tang-Huau, Tsing-Lee, Li, Rong, Saturday, Greg, Feldmann, Friederike, Scott, Dana, Wang, Zhongde, Munster, Vincent, Jarvis, Michael A., Feldmann, Heinz
Format Journal Article
LanguageEnglish
Published United States Taylor & Francis 01.01.2020
Taylor & Francis Ltd
Taylor & Francis Group
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Following emergence in late 2019, SARS-CoV-2 rapidly became pandemic and is presently responsible for millions of infections and hundreds of thousands of deaths worldwide. There is currently no approved vaccine to halt the spread of SARS-CoV-2 and only very few treatment options are available to manage COVID-19 patients. For development of preclinical countermeasures, reliable and well-characterized small animal disease models will be of paramount importance. Here we show that intranasal inoculation of SARS-CoV-2 into Syrian hamsters consistently caused moderate broncho-interstitial pneumonia, with high viral lung loads and extensive virus shedding, but animals only displayed transient mild disease. We determined the infectious dose 50 to be only five infectious particles, making the Syrian hamster a highly susceptible model for SARS-CoV-2 infection. Neither hamster age nor sex had any impact on the severity of disease or course of infection. Finally, prolonged viral persistence in interleukin 2 receptor gamma chain knockout hamsters revealed susceptibility of SARS-CoV-2 to adaptive immune control. In conclusion, the Syrian hamster is highly susceptible to SARS-CoV-2 making it a very suitable infection model for COVID-19 countermeasure development.
AbstractList Following emergence in late 2019, SARS-CoV-2 rapidly became pandemic and is presently responsible for millions of infections and hundreds of thousands of deaths worldwide. There is currently no approved vaccine to halt the spread of SARS-CoV-2 and only very few treatment options are available to manage COVID-19 patients. For development of preclinical countermeasures, reliable and well-characterized small animal disease models will be of paramount importance. Here we show that intranasal inoculation of SARS-CoV-2 into Syrian hamsters consistently caused moderate broncho-interstitial pneumonia, with high viral lung loads and extensive virus shedding, but animals only displayed transient mild disease. We determined the infectious dose 50 to be only five infectious particles, making the Syrian hamster a highly susceptible model for SARS-CoV-2 infection. Neither hamster age nor sex had any impact on the severity of disease or course of infection. Finally, prolonged viral persistence in interleukin 2 receptor gamma chain knockout hamsters revealed susceptibility of SARS-CoV-2 to adaptive immune control. In conclusion, the Syrian hamster is highly susceptible to SARS-CoV-2 making it a very suitable infection model for COVID-19 countermeasure development.
Following emergence in late 2019, SARS-CoV-2 rapidly became pandemic and is presently responsible for millions of infections and hundreds of thousands of deaths worldwide. There is currently no approved vaccine to halt the spread of SARS-CoV-2 and only very few treatment options are available to manage COVID-19 patients. For development of preclinical countermeasures, reliable and well-characterized small animal disease models will be of paramount importance. Here we show that intranasal inoculation of SARS-CoV-2 into Syrian hamsters consistently caused moderate broncho-interstitial pneumonia, with high viral lung loads and extensive virus shedding, but animals only displayed transient mild disease. We determined the infectious dose 50 to be only five infectious particles, making the Syrian hamster a highly susceptible model for SARS-CoV-2 infection. Neither hamster age nor sex had any impact on the severity of disease or course of infection. Finally, prolonged viral persistence in interleukin 2 receptor gamma chain knockout hamsters revealed susceptibility of SARS-CoV-2 to adaptive immune control. In conclusion, the Syrian hamster is highly susceptible to SARS-CoV-2 making it a very suitable infection model for COVID-19 countermeasure development.Following emergence in late 2019, SARS-CoV-2 rapidly became pandemic and is presently responsible for millions of infections and hundreds of thousands of deaths worldwide. There is currently no approved vaccine to halt the spread of SARS-CoV-2 and only very few treatment options are available to manage COVID-19 patients. For development of preclinical countermeasures, reliable and well-characterized small animal disease models will be of paramount importance. Here we show that intranasal inoculation of SARS-CoV-2 into Syrian hamsters consistently caused moderate broncho-interstitial pneumonia, with high viral lung loads and extensive virus shedding, but animals only displayed transient mild disease. We determined the infectious dose 50 to be only five infectious particles, making the Syrian hamster a highly susceptible model for SARS-CoV-2 infection. Neither hamster age nor sex had any impact on the severity of disease or course of infection. Finally, prolonged viral persistence in interleukin 2 receptor gamma chain knockout hamsters revealed susceptibility of SARS-CoV-2 to adaptive immune control. In conclusion, the Syrian hamster is highly susceptible to SARS-CoV-2 making it a very suitable infection model for COVID-19 countermeasure development.
Author Li, Rong
Jarvis, Michael A.
Feldmann, Heinz
Letko, Michael
Feldmann, Friederike
Okumura, Atsushi
Hansen, Frederick
Wang, Zhongde
Liu, Yanan
Scott, Dana
Saturday, Greg
Clancy, Chad
Tang-Huau, Tsing-Lee
Munster, Vincent
Meade-White, Kimberly
Rosenke, Kyle
Author_xml – sequence: 1
  givenname: Kyle
  surname: Rosenke
  fullname: Rosenke, Kyle
  organization: Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health
– sequence: 2
  givenname: Kimberly
  surname: Meade-White
  fullname: Meade-White, Kimberly
  organization: Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health
– sequence: 3
  givenname: Michael
  surname: Letko
  fullname: Letko, Michael
  organization: Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health
– sequence: 4
  givenname: Chad
  surname: Clancy
  fullname: Clancy, Chad
  organization: Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health
– sequence: 5
  givenname: Frederick
  surname: Hansen
  fullname: Hansen, Frederick
  organization: Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health
– sequence: 6
  givenname: Yanan
  surname: Liu
  fullname: Liu, Yanan
  organization: Utah State University
– sequence: 7
  givenname: Atsushi
  surname: Okumura
  fullname: Okumura, Atsushi
  organization: Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health
– sequence: 8
  givenname: Tsing-Lee
  surname: Tang-Huau
  fullname: Tang-Huau, Tsing-Lee
  organization: Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health
– sequence: 9
  givenname: Rong
  surname: Li
  fullname: Li, Rong
  organization: Utah State University
– sequence: 10
  givenname: Greg
  surname: Saturday
  fullname: Saturday, Greg
  organization: Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health
– sequence: 11
  givenname: Friederike
  surname: Feldmann
  fullname: Feldmann, Friederike
  organization: Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health
– sequence: 12
  givenname: Dana
  surname: Scott
  fullname: Scott, Dana
  organization: Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health
– sequence: 13
  givenname: Zhongde
  surname: Wang
  fullname: Wang, Zhongde
  organization: Utah State University
– sequence: 14
  givenname: Vincent
  orcidid: 0000-0002-2288-3196
  surname: Munster
  fullname: Munster, Vincent
  organization: Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health
– sequence: 15
  givenname: Michael A.
  surname: Jarvis
  fullname: Jarvis, Michael A.
  organization: Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health
– sequence: 16
  givenname: Heinz
  orcidid: 0000-0001-9448-8227
  surname: Feldmann
  fullname: Feldmann, Heinz
  email: feldmannh@niaid.nih.gov
  organization: Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health
BackLink https://www.ncbi.nlm.nih.gov/pubmed/33251966$$D View this record in MEDLINE/PubMed
BookMark eNqFUk1v1DAQjVARLaU_AWSJC5cU23FiR0iIavmqVAmJBY5YE9vZeOXYWzsL2n-Pw26rtgeYi62Z957HM-9pceSDN0XxnOBzggV-TXMQXpNzimlOiVoQzh8VJ3O-nAtHd-7HxVlKa5yD44YR9qQ4ripak7ZpToqf701vvfUrNA0GLXfRgkcDjGkyEUFCgAa7GtwOpW1SZjPZzhm0iUa5zFLg0Bi0cagPES0vvi7LRfhRUmR9b9Rkg39WPO7BJXN2OE-L7x8_fFt8Lq--fLpcXFyVqqFiKjVta4FxywhoXIlGG9URUdG-w73osAHgDdMCOlbxDkzbY8UoqVummCZUm-q0uNzr6gBruYl2hLiTAaz8mwhxJSFOVjkjia6AEE4b0ub3lOqo5ox1NcfA-qoXWevtXmuz7UajlfFTBHdP9H7F20Guwi_JuaC0abLAq4NADNdbkyY52jw858CbsE2SsqbmdVtjnKEvH0DXYRt9HpWkNRZzlw3LqBd3O7pt5WaNGVDvASqGlKLpbyEEy9kx8sYxcnaMPDgm89484Ck7wby4_DHr_st-t2fndYc4wu8QnZYT7FyIfQSvbJLVvyX-ACaq14A
CitedBy_id crossref_primary_10_1038_s41392_022_01039_2
crossref_primary_10_1080_22221751_2021_1997074
crossref_primary_10_1371_journal_ppat_1010741
crossref_primary_10_1126_scisignal_adg5470
crossref_primary_10_1016_j_ebiom_2021_103403
crossref_primary_10_3389_fimmu_2023_941281
crossref_primary_10_2139_ssrn_3915655
crossref_primary_10_1038_s41591_022_01780_9
crossref_primary_10_1111_cbdd_13954
crossref_primary_10_3390_microorganisms10020407
crossref_primary_10_3390_ijms24065352
crossref_primary_10_3390_v14061218
crossref_primary_10_1002_mco2_98
crossref_primary_10_1002_jmv_28103
crossref_primary_10_2139_ssrn_3929650
crossref_primary_10_1172_jci_insight_159573
crossref_primary_10_1038_s41467_025_55938_3
crossref_primary_10_1038_s42003_023_04589_5
crossref_primary_10_1093_ilar_ilab007
crossref_primary_10_3390_covid2110111
crossref_primary_10_1038_s41564_021_01047_y
crossref_primary_10_1016_j_coviro_2021_03_009
crossref_primary_10_3390_v13081653
crossref_primary_10_3389_fimmu_2021_788235
crossref_primary_10_1186_s13567_021_00988_w
crossref_primary_10_1016_j_isci_2025_111875
crossref_primary_10_1080_20477724_2023_2228048
crossref_primary_10_1080_22221751_2023_2178242
crossref_primary_10_1126_sciimmunol_abm3131
crossref_primary_10_1111_xen_12772
crossref_primary_10_1038_s41598_022_23339_x
crossref_primary_10_1080_26895293_2025_2468334
crossref_primary_10_3390_vaccines11121831
crossref_primary_10_7554_eLife_75537
crossref_primary_10_1093_cid_ciab903
crossref_primary_10_3390_v13101993
crossref_primary_10_1177_03009858211057197
crossref_primary_10_3390_v16020246
crossref_primary_10_3390_pathogens12010020
crossref_primary_10_1016_j_ebiom_2023_104597
crossref_primary_10_1128_mBio_00974_21
crossref_primary_10_1093_biosci_biad102
crossref_primary_10_3390_pathogens10070824
crossref_primary_10_1038_s41467_023_42140_6
crossref_primary_10_3389_fimmu_2022_1080897
crossref_primary_10_1038_s44298_023_00012_2
crossref_primary_10_3389_fimmu_2022_836745
crossref_primary_10_1128_jvi_01366_22
crossref_primary_10_1186_s13578_024_01280_y
crossref_primary_10_1128_mBio_02527_21
crossref_primary_10_3390_v14020418
crossref_primary_10_1038_s41467_021_25156_8
crossref_primary_10_7554_eLife_73522
crossref_primary_10_3390_vaccines9040340
crossref_primary_10_1007_s00439_023_02549_x
crossref_primary_10_1016_j_biochi_2021_06_005
crossref_primary_10_1002_ame2_12278
crossref_primary_10_1016_j_celrep_2022_111002
crossref_primary_10_1016_j_ebiom_2022_104203
crossref_primary_10_1111_cbdd_14035
crossref_primary_10_1128_spectrum_04998_22
crossref_primary_10_1016_j_bbi_2024_10_032
crossref_primary_10_3390_v15112151
crossref_primary_10_1016_j_antiviral_2023_105605
crossref_primary_10_1038_s41467_021_22580_8
crossref_primary_10_1096_fj_202100431R
crossref_primary_10_1126_scitranslmed_abh0755
crossref_primary_10_7554_eLife_87094
crossref_primary_10_1038_s41598_021_00843_0
crossref_primary_10_1177_01926233211072767
crossref_primary_10_36233_0372_9311_528
crossref_primary_10_1016_j_virs_2022_09_008
crossref_primary_10_1038_s41421_024_00734_4
crossref_primary_10_1155_2023_1868732
crossref_primary_10_3390_v15030725
crossref_primary_10_1038_s41598_022_09218_5
crossref_primary_10_1002_jmv_70237
crossref_primary_10_3390_v17010100
crossref_primary_10_1002_advs_202202771
crossref_primary_10_1038_s41392_024_01917_x
crossref_primary_10_1111_ina_13118
crossref_primary_10_1080_22221751_2021_1943539
crossref_primary_10_3389_fcimb_2022_979641
crossref_primary_10_3390_biomedicines12030642
crossref_primary_10_3390_pathogens12030364
crossref_primary_10_3390_v14030639
crossref_primary_10_30802_AALAS_CM_21_000046
crossref_primary_10_1016_j_ebiom_2025_105615
crossref_primary_10_1038_s41392_022_01087_8
crossref_primary_10_1016_j_ebiom_2021_103675
crossref_primary_10_1177_03009858211067468
crossref_primary_10_3389_fmicb_2023_1148255
crossref_primary_10_7554_eLife_87094_3
crossref_primary_10_30621_jbachs_1315023
crossref_primary_10_3389_fimmu_2023_1060540
crossref_primary_10_1371_journal_ppat_1009705
crossref_primary_10_2139_ssrn_4151032
crossref_primary_10_1038_s41556_021_00821_8
crossref_primary_10_1371_journal_ppat_1010807
crossref_primary_10_2174_2666796704666230330083413
crossref_primary_10_1016_j_coviro_2023_101375
crossref_primary_10_30802_AALAS_CM_21_000036
crossref_primary_10_1016_j_cell_2021_02_026
crossref_primary_10_1128_spectrum_01789_21
crossref_primary_10_1016_j_medj_2022_03_009
crossref_primary_10_1016_j_ajpath_2023_02_013
crossref_primary_10_1371_journal_ppat_1011298
crossref_primary_10_3390_v13122506
crossref_primary_10_3390_v15030748
crossref_primary_10_3389_fviro_2022_891540
crossref_primary_10_3389_fimmu_2023_1223260
crossref_primary_10_1177_20503121221115053
crossref_primary_10_1016_j_dib_2023_109158
crossref_primary_10_1098_rsif_2024_0009
crossref_primary_10_1080_22221751_2022_2058419
crossref_primary_10_36233_0507_4088_63
crossref_primary_10_1093_infdis_jiab289
crossref_primary_10_1371_journal_ppat_1011293
crossref_primary_10_1016_j_omtm_2023_06_009
crossref_primary_10_1016_j_vaccine_2022_03_064
crossref_primary_10_1080_21505594_2024_2316438
crossref_primary_10_3390_biomedicines10061343
crossref_primary_10_1007_s11250_023_03470_1
crossref_primary_10_1038_s43587_021_00156_x
crossref_primary_10_1080_08958378_2024_2412685
crossref_primary_10_1172_jci_insight_163962
crossref_primary_10_1128_mBio_01415_21
crossref_primary_10_1016_j_isci_2022_105074
crossref_primary_10_3390_v13050815
crossref_primary_10_1172_jci_insight_160108
crossref_primary_10_3390_pathogens11101112
crossref_primary_10_3390_v13112251
crossref_primary_10_1152_ajpregu_00356_2020
crossref_primary_10_1016_j_ebiom_2022_104248
crossref_primary_10_1161_CIRCRESAHA_121_320518
crossref_primary_10_1038_s41467_023_39049_5
crossref_primary_10_1038_s44298_024_00061_1
crossref_primary_10_3389_fvets_2024_1435464
crossref_primary_10_3390_cimb45010019
crossref_primary_10_1016_j_antiviral_2022_105345
crossref_primary_10_1016_j_biopha_2022_112872
crossref_primary_10_1128_mbio_00078_23
crossref_primary_10_1038_s41598_022_19222_4
crossref_primary_10_1016_j_chom_2022_01_006
crossref_primary_10_3390_vaccines10030435
crossref_primary_10_1016_j_celrep_2022_110515
crossref_primary_10_1371_journal_pone_0257191
crossref_primary_10_3390_vaccines11121771
crossref_primary_10_3390_v15010085
Cites_doi 10.3851/IMP3368
10.1101/2020.05.14.096727
10.1128/JVI.00127-20
10.1016/j.cell.2020.05.027
10.1016/j.chom.2020.03.023
10.1038/s41586-020-2342-5
10.1101/2020.06.29.177154
10.3390/ijms21082948
10.1016/S0140-6736(20)30211-7
10.1016/S2666-5247(20)30089-6
10.1101/2020.05.27.118893
10.3345/cep.2020.00493
10.1128/JVI.02012-06
10.1073/pnas.2009799117
10.1016/j.immuni.2019.03.028
10.1101/2020.05.02.073411
10.1016/j.cell.2020.06.011
10.1016/j.ijantimicag.2020.105949
10.1001/jama.2020.5394
10.1101/2020.05.06.081497
10.1242/dmm.044602
10.1038/s41564-020-0688-y
10.1093/oxfordjournals.aje.a118408
10.1038/s41586-020-2312-y
10.1126/science.abb7015
10.1126/science.abb7314
10.1038/s41586-020-2324-7
10.2807/1560-7917.ES.2020.25.3.2000045
10.1016/j.chom.2020.05.020
10.3201/eid2606.200516
10.1001/jama.2020.1585
10.1128/JVI.01702-06
10.1007/s13238-020-00767-x
10.1038/s41586-020-2012-7
10.1128/JVI.00737-08
ContentType Journal Article
Copyright 2020 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group, on behalf of Shanghai Shangyixun Cultural Communication Co., Ltd 2020
This work was authored as part of the Contributor's official duties as an Employee of the United States Government and is therefore a work of the United States Government. In accordance with 17 U.S.C. 105, no copyright protection is available for such works under U.S. Law. . This work is licensed under the Creative Commons Attribution License http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
2020 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group, on behalf of Shanghai Shangyixun Cultural Communication Co., Ltd 2020 The Author(s)
Copyright_xml – notice: 2020 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group, on behalf of Shanghai Shangyixun Cultural Communication Co., Ltd 2020
– notice: This work was authored as part of the Contributor's official duties as an Employee of the United States Government and is therefore a work of the United States Government. In accordance with 17 U.S.C. 105, no copyright protection is available for such works under U.S. Law. . This work is licensed under the Creative Commons Attribution License http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: 2020 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group, on behalf of Shanghai Shangyixun Cultural Communication Co., Ltd 2020 The Author(s)
DBID 0YH
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7X7
7XB
88E
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
COVID
DWQXO
FYUFA
GHDGH
K9.
M0S
M1P
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
DOA
DOI 10.1080/22221751.2020.1858177
DatabaseName Taylor & Francis Open Access
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Health & Medical Collection (ProQuest)
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials - QC
ProQuest Central
ProQuest One
Coronavirus Research Database
ProQuest Central Korea
Proquest Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
ProQuest Health & Medical Collection
Medical Database
ProQuest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Central China
ProQuest Central
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Health & Medical Research Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest One Academic Eastern Edition
Coronavirus Research Database
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList
MEDLINE
Publicly Available Content Database
MEDLINE - Academic


Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: 0YH
  name: Taylor & Francis Open Access
  url: https://www.tandfonline.com
  sourceTypes: Publisher
– sequence: 5
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Public Health
DocumentTitleAlternate Emerging Microbes & Infections
EISSN 2222-1751
EndPage 2684
ExternalDocumentID oai_doaj_org_article_1d3a1172619941ccb2d744b570a4f3f8
PMC7782266
33251966
10_1080_22221751_2020_1858177
1858177
Genre Research Article
Journal Article
GrantInformation_xml – fundername: National Institutes of Allergy and Infectious Diseases (NIAID)
– fundername: National Institutes of Health (NIH)
– fundername: Division of Intramural Research, National Institute of Allergy and Infectious Diseases
  funderid: 10.13039/100006492
GroupedDBID 0YH
3V.
53G
5VS
7X7
88E
8FI
8FJ
AAHBH
ABUWG
ACGFS
ADBBV
ADRAZ
AENEX
AFKRA
AJTQC
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BENPR
BPHCQ
BVXVI
C6C
CCPQU
DIK
EBS
ECGQY
EMOBN
FYUFA
GROUPED_DOAJ
HMCUK
HYE
KQ8
M1P
M48
M4Z
M~E
NAO
OK1
PIMPY
PQQKQ
PROAC
PSQYO
RNT
RNTTT
RPM
TDBHL
UKHRP
AAYXX
BCNDV
CITATION
EJD
PHGZM
PHGZT
CGR
CUY
CVF
ECM
EIF
NPM
7XB
8FK
AZQEC
COVID
DWQXO
K9.
PJZUB
PKEHL
PPXIY
PQEST
PQUKI
PRINS
7X8
5PM
PUEGO
ID FETCH-LOGICAL-c628t-d295800941ad0386decb1832fb0f8b0eaa764d8ab437bae9f0c421594c4d12de3
IEDL.DBID M48
ISSN 2222-1751
IngestDate Wed Aug 27 01:26:14 EDT 2025
Thu Aug 21 13:29:59 EDT 2025
Fri Jul 11 11:32:45 EDT 2025
Fri Jul 25 20:52:50 EDT 2025
Thu Jan 02 22:56:00 EST 2025
Thu Apr 24 22:52:33 EDT 2025
Tue Jul 01 05:04:30 EDT 2025
Wed Dec 25 09:05:03 EST 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords SARS-CoV-2
infection model
pneumonia
hamster
susceptible
Language English
License open-access: http://creativecommons.org/licenses/by/4.0/: This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c628t-d295800941ad0386decb1832fb0f8b0eaa764d8ab437bae9f0c421594c4d12de3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
Supplemental data for this article can be accessed at https://doi.org/10.1080/22221751.2020.1858177
Current affiliation: Paul G. Allen School for Global Animal Health, Washington State University, Pullman, WA, USA.
ORCID 0000-0001-9448-8227
0000-0002-2288-3196
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.1080/22221751.2020.1858177
PMID 33251966
PQID 2508726164
PQPubID 2041957
PageCount 12
ParticipantIDs doaj_primary_oai_doaj_org_article_1d3a1172619941ccb2d744b570a4f3f8
crossref_primary_10_1080_22221751_2020_1858177
pubmedcentral_primary_oai_pubmedcentral_nih_gov_7782266
crossref_citationtrail_10_1080_22221751_2020_1858177
pubmed_primary_33251966
proquest_miscellaneous_2465759500
informaworld_taylorfrancis_310_1080_22221751_2020_1858177
proquest_journals_2508726164
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2020-01-01
PublicationDateYYYYMMDD 2020-01-01
PublicationDate_xml – month: 01
  year: 2020
  text: 2020-01-01
  day: 01
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: London
PublicationTitle Emerging microbes & infections
PublicationTitleAlternate Emerg Microbes Infect
PublicationYear 2020
Publisher Taylor & Francis
Taylor & Francis Ltd
Taylor & Francis Group
Publisher_xml – name: Taylor & Francis
– name: Taylor & Francis Ltd
– name: Taylor & Francis Group
References e_1_3_5_29_1
e_1_3_5_28_1
e_1_3_5_27_1
e_1_3_5_26_1
e_1_3_5_25_1
e_1_3_5_24_1
e_1_3_5_23_1
e_1_3_5_22_1
Conti P (e_1_3_5_38_1) 2020; 34
e_1_3_5_3_1
e_1_3_5_2_1
e_1_3_5_40_1
e_1_3_5_41_1
e_1_3_5_42_1
e_1_3_5_9_1
e_1_3_5_21_1
e_1_3_5_20_1
Allenspach E (e_1_3_5_36_1) 1993
e_1_3_5_5_1
e_1_3_5_4_1
e_1_3_5_6_1
e_1_3_5_18_1
e_1_3_5_17_1
e_1_3_5_39_1
e_1_3_5_16_1
e_1_3_5_15_1
e_1_3_5_37_1
e_1_3_5_13_1
e_1_3_5_14_1
e_1_3_5_35_1
e_1_3_5_11_1
e_1_3_5_34_1
e_1_3_5_12_1
e_1_3_5_33_1
e_1_3_5_19_1
Sanders JM (e_1_3_5_7_1) 2020; 323
Ali MJ (e_1_3_5_8_1) 2020; 7
e_1_3_5_32_1
e_1_3_5_10_1
e_1_3_5_31_1
e_1_3_5_30_1
32995767 - bioRxiv. 2020 Sep 27
References_xml – ident: e_1_3_5_9_1
  doi: 10.3851/IMP3368
– ident: e_1_3_5_11_1
  doi: 10.1101/2020.05.14.096727
– ident: e_1_3_5_22_1
  doi: 10.1128/JVI.00127-20
– ident: e_1_3_5_41_1
  doi: 10.1016/j.cell.2020.05.027
– ident: e_1_3_5_13_1
  doi: 10.1016/j.chom.2020.03.023
– ident: e_1_3_5_20_1
  doi: 10.1038/s41586-020-2342-5
– ident: e_1_3_5_34_1
  doi: 10.1101/2020.06.29.177154
– ident: e_1_3_5_37_1
  doi: 10.3390/ijms21082948
– ident: e_1_3_5_4_1
  doi: 10.1016/S0140-6736(20)30211-7
– ident: e_1_3_5_14_1
  doi: 10.1016/S2666-5247(20)30089-6
– ident: e_1_3_5_24_1
  doi: 10.1101/2020.05.27.118893
– ident: e_1_3_5_40_1
  doi: 10.3345/cep.2020.00493
– ident: e_1_3_5_25_1
  doi: 10.1128/JVI.02012-06
– ident: e_1_3_5_18_1
  doi: 10.1073/pnas.2009799117
– ident: e_1_3_5_35_1
  doi: 10.1016/j.immuni.2019.03.028
– ident: e_1_3_5_19_1
  doi: 10.1101/2020.05.02.073411
– ident: e_1_3_5_23_1
  doi: 10.1016/j.cell.2020.06.011
– ident: e_1_3_5_6_1
  doi: 10.1016/j.ijantimicag.2020.105949
– ident: e_1_3_5_39_1
  doi: 10.1001/jama.2020.5394
– ident: e_1_3_5_16_1
  doi: 10.1101/2020.05.06.081497
– ident: e_1_3_5_30_1
  doi: 10.1242/dmm.044602
– ident: e_1_3_5_2_1
– ident: e_1_3_5_21_1
  doi: 10.1038/s41564-020-0688-y
– ident: e_1_3_5_31_1
  doi: 10.1093/oxfordjournals.aje.a118408
– volume: 34
  issue: 2
  year: 2020
  ident: e_1_3_5_38_1
  article-title: Coronavirus COV-19/SARS-CoV-2 affects women less than men: clinical response to viral infection
  publication-title: J Biol Regul Homeost Agents
– ident: e_1_3_5_17_1
  doi: 10.1038/s41586-020-2312-y
– ident: e_1_3_5_15_1
  doi: 10.1126/science.abb7015
– ident: e_1_3_5_12_1
  doi: 10.1126/science.abb7314
– ident: e_1_3_5_10_1
  doi: 10.1038/s41586-020-2324-7
– volume: 7
  issue: 480
  year: 2020
  ident: e_1_3_5_8_1
  article-title: Treatment options for COVID-19: a review
  publication-title: Front Med (Lausanne)
– ident: e_1_3_5_3_1
– ident: e_1_3_5_32_1
  doi: 10.2807/1560-7917.ES.2020.25.3.2000045
– ident: e_1_3_5_27_1
  doi: 10.1016/j.chom.2020.05.020
– ident: e_1_3_5_29_1
  doi: 10.3201/eid2606.200516
– ident: e_1_3_5_5_1
  doi: 10.1001/jama.2020.1585
– ident: e_1_3_5_26_1
  doi: 10.1128/JVI.01702-06
– ident: e_1_3_5_28_1
  doi: 10.1007/s13238-020-00767-x
– volume: 323
  start-page: 1824
  issue: 18
  year: 2020
  ident: e_1_3_5_7_1
  article-title: Pharmacologic treatments for coronavirus disease 2019 (COVID-19): a review
  publication-title: JAMA
– ident: e_1_3_5_33_1
  doi: 10.1038/s41586-020-2012-7
– volume-title: X-linked severe combined immunodeficiency
  year: 1993
  ident: e_1_3_5_36_1
– ident: e_1_3_5_42_1
  doi: 10.1128/JVI.00737-08
– reference: 32995767 - bioRxiv. 2020 Sep 27;:
SSID ssj0000706414
Score 2.5378768
Snippet Following emergence in late 2019, SARS-CoV-2 rapidly became pandemic and is presently responsible for millions of infections and hundreds of thousands of...
SourceID doaj
pubmedcentral
proquest
pubmed
crossref
informaworld
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 2673
SubjectTerms Animals
Chlorocebus aethiops
Coronaviruses
COVID-19
COVID-19 - etiology
COVID-19 - immunology
COVID-19 - pathology
Cricetinae
Disease Models, Animal
Disease Susceptibility
Female
hamster
infection model
Infections
Lung - pathology
Male
Mesocricetus
pneumonia
Receptors, Interleukin-2 - physiology
RNA, Viral - analysis
SARS-CoV-2
Severe acute respiratory syndrome coronavirus 2
Spike Glycoprotein, Coronavirus - metabolism
susceptible
Vero Cells
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LT9wwELYqTpUq1AeFtLRyJa4pduz4cQRahCq1h26pOGH5FVFpyaLu7oF_j8dOVrsIaS9c_VA8nhnPxJ75BqEjF0QQjMXae-Fr3gRWOw21XniyL13QrqSP_fwlLi75j6v2aq3UF8SEFXjgsnHHNDBLk5UVAGJLvXdNkJy7VhLLO9blNN9k89Z-pvIZLJOppXxM2VHkONnB5H238EvYpCbVKirlhjHKmP2PEEuf8jsfh0-u2aPz12h3cCTxSSHgDXoR-7foVbmFwyW56B26_ha7XAECJz8PT-6TtPX4xt4COgK2c2wxwBVP7_F8Oc_xLW4a8V06BId8SZwL5eC0Ujw5-T2pz2Z_6waPAVz9Hro8__7n7KIeKirUXjRqUYdGtwqCCakNhCkRoneg050jnXIkWisFD8o6zqSzUXfEA8809zzQJkT2Hu30sz4eIOzTEGVb5rzSXFvmhFBUSOGUJ04yVSE-bq3xA9w4VL2YGjqgko4cMcARM3CkQl9X0-4K3sa2CafAt9VggMvODUmIzCBEZpsQVUivc90s8m1JV0qbGLZlAYejiJhB_-cmOZYKPid4hb6supPmwnOM7eNsmcZwePTSLSEV2i8StaKCMcgoFqJCckPWNsjc7On_3WR0cAk-nxAfnmNfPqKXQGq5cjpEO4v_y_gpOWEL9znr2wNbrygc
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Health & Medical Collection (ProQuest)
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV1Lb9QwELagXJAQ4k2gICNxNU1ix48TKoWqQoIDS9GesPwKRVqSpdk99N_jcZzQrRC9xrZke54Zz3yD0GvrueeUBuIcd4TVnhKroNcLi_al9cqO5WOfPvOTU_Zx2SxzwG3IaZWTTkyK2vcOYuQH0VRLEd19zt6ufxPoGgWvq7mFxk10C6DLIKVLLMUcY4nszFnFpsIdWR5Eaxh98AZ-DOv4STayEmLHJCXk_iu4pf_yPq8mUV6ySsf30N3sTuLDkf730Y3QPUB3xlgcHkuMHqLv70Ob-kDg6O3hxUXkuQ6fmV-AkYDNgA0G0OLVBR62Q8pysauA11EV5qpJnNrl4LhTvDj8siBH_TdS4ymNq3uETo8_fD06IbmvAnG8lhvi63hVkFJYGV9SyX1wFiS7tWUrbRmMEZx5aSyjwpqg2tIB5RRzzFe1D_Qx2uv6LjxF2MUp0jTUOqmYMtRyLisuuJWutILKArHparXLoOPQ-2Klq4xNOlFEA0V0pkiB3szL1iPqxnUL3gHd5skAmp0-9Oc_dJZBXXlqqgqYSMWzO2drLxizjSgNa2kbN6suU11vUsykHRucaHrNBvYnFtFZCwz6L88W6NU8HOUXHmVMF_ptnMPg6Us1ZVmgJyNHzaegFOqKOS-Q2OG1nWPujnQ_zxJGuADPj_Nn_9_Wc3QbDjGGlPbR3uZ8G15EJ2tjXyZJ-gP0uCBX
  priority: 102
  providerName: ProQuest
– databaseName: Taylor & Francis Open Access
  dbid: 0YH
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwELagXJAQ4k2gICNxDTixM3aOpVCtkODAUgQXLL_SIi3Zqtk99N_jcZyoW4F64BjHVuzMjGc8nvmGkNfWgwfOQ-kcuFLUnpe2xVovIuqXzrd2TB_79BkWx-Lj92aKJhxyWCWeobsRKCLt1Sjcxg5TRNzbqNKiId3g6a6OTapRlZQ3ya0auTWyNPuxmN0skaNBVGLK3fnX6B2tlMD7r0CX_s0AvRpHeUkxHd0jd7NFSQ9GFrhPboT-AbkzuuPomGX0kPx8H7pUCoJGg48uLyLb9fTU_EaYBGoGaijiFq8u6LAdUqCLXQV6FnfDnDhJU8UcGmdKlwdfluXh-ltZ0ymSq39Ejo8-fD1clLm0QumgVpvS122jMKqwMp5xBT44i8LdWdYpy4IxEoRXxgourQltxxwSrxVO-Kr2gT8me_26D08JdbGLMg23TrWiNdwCqAokWOWYlVwVREy_VruMO47lL1a6yvCkE0U0UkRnihTkzTzsbATeuG7AO6Tb3Blxs1PD-vxEZzHUleemijYbICRy5ZytvRTCNpIZ0fEuTra9THW9SW6Tbqxxovk1E9ifWETnjWDQ0cJU-DkQBXk1v44ijPcypg_rbewj8ParbRgryJORo-ZVcI6pxQAFkTu8trPM3Tf9r9MEEy7R-AN49h9Lek5u4-Poctone5vzbXgRjbCNfZnE7A_75SWe
  priority: 102
  providerName: Taylor & Francis
Title Defining the Syrian hamster as a highly susceptible preclinical model for SARS-CoV-2 infection
URI https://www.tandfonline.com/doi/abs/10.1080/22221751.2020.1858177
https://www.ncbi.nlm.nih.gov/pubmed/33251966
https://www.proquest.com/docview/2508726164
https://www.proquest.com/docview/2465759500
https://pubmed.ncbi.nlm.nih.gov/PMC7782266
https://doaj.org/article/1d3a1172619941ccb2d744b570a4f3f8
Volume 9
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Za9wwEB5yvBRKaXpumy4q9NWpbcmS_FBKTpZCQsl2y_alRpebwtab7gHdf1-NLC_ZkBL6YrAt2bJmxvNZnvkG4J223HJKXWIMNwnLLU10ibVemPcvtS11mz52fsEHI_ZpXIy3oCNUiBM4v_PTDutJjWaTgz-_Vx-9wX-IEXLvvYvzwLrAr73cH5KFzITYhl3vnATa6nlE_OHlLLwPDozf2CvBbl1ez7-utOGxArH_LVrTu8Dp7RjLG07r7DE8imiTHLbqsQdbrnkCD9ulOtJmID2F7yeuDmUiiAeDZLjyKtmQK_ULKRSImhNFkNN4siLz5TwEweiJI9f-TRmTKkmopkP8SMnw8HKYHE-_JjnporyaZzA6O_1yPEhi2YXE8FwuEpuXhcSIw0zZlEpundFo-LVOa6lTp5TgzEqlGRVaubJODQq2ZIbZLLeOPoedZtq4l0CMbyJVQbWRJSsV1ZzLjAuupUm1oLIHrJvaykROciyNMamySF3aSaRCiVRRIj04WHe7bkk57utwhHJbN0ZO7XBgOvtRRROtMktV5vEcR7rkzBidW8GYLkSqWE1rP9jyptSrRVhSqdv6JxW9ZwD7nYpUnY5XHn1KvB1nPXi7Pu3NG__ZqMZNl74Nwz9jZZGmPXjRatT6KSjFtGPOeyA2dG3jMTfPND-vAoW4QGDI-av_ncjX8AB32zWofdhZzJbujUdlC92H7fTbwG_FWPRh9-j04vNlP6xw9IMF_gUqyC4R
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtR3JbhMx9KmkB5AQYidQwEhwHDoz9tieA0JdldI2Qk2LeqrxNhQpTEKTCOWn-Eb8ZglNheip17E9evZb_fwWgLfGcccp9ZG13EYsdTQyOfZ6YUG_FC43dfrYYZ_3Ttin0-x0BX63uTAYVtnKxEpQu5FFH_l6UNVSBHOfs4_jnxF2jcLX1baFRk0W-37-K1zZJh_2tgN-36Xp7s7xVi9qugpElqdyGrk0zyQG1CXaxVRy561Bui5MXEgTe60FZ05qw6gw2udFbBHunFnmktR5Gv57C1YZDVeZDqxu7vQ_Hy28OoGBOEtYmyok4_Wgf4PVn-FVNA2fZCYTIZaUYNUr4Eql1H_Zu1fDNi_pwd37cK8xYMlGTXEPYMWXD-Fu7f0jdVLTIzjb9kXVeYIE-5IM5oHKS3Kuf2BVBqInRBMskzyck8lsUsXVmKEn4yB8mzxNUjXoIQFSMtg4GkRboy9RStrAsfIxnNzImT-BTjkq_TMgNkyROqPGypzlmhrOZcIFN9LGRlDZBdYerbJNmXPstjFUSVMNtcWIQoyoBiNdeL9YNq7rfFy3YBPxtpiMZbqrD6OLb6rhepU4qpMEyTYPe7fWpE4wZjIRa1bQIgCbX8a6mlZemqJuqaLoNQCstSSiGrkzUX-5pAtvFsNBYuAzkC79aBbmMHxsy7M47sLTmqIWu6AUM5k574JYorWlbS6PlN_Pq6rkAm1Nzp__H6zXcLt3fHigDvb6-y_gDm6odmitQWd6MfMvg4k3Na8aviLw9aZZ-Q_pxl8A
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwELagSAgJofIqgRaMxDUQx47tHEvb1fKqEEsRXLD8pEhLdtXsHvrv8SRO1K2oeuDqh2JnZjzj8cw3CL0yjjtOqc-t5TZnpaO5qaHWC4v6Jbja9Oljn4759IS9_14N0YRtCquEO3TogSK6sxqEe-nCEBH3Jqq0aEhXcLsrY5OsJBHiJrpVyajrI0sXP6ajmyVyNGeEDbk7V83e0EodeP8l6NJ_GaCX4ygvKKbJNrqXLEq837PAfXTDNw_Q3d4dh_sso4fo56EPXSkIHA0-PDuPbNfgU_0HYBKwbrHGgFs8P8ftuu0CXczc42U8DVPiJO4q5uC4Ujzb_zLLDxbf8hIPkVzNI3QyOfp6MM1TaYXc8lKuclfWlYSoQqJdQSV33hoQ7mCKIE3htRacOakNo8JoX4fCAvFqZpkjpfP0MdpqFo1_grCNQ6SuqLGyZrWmhnNJuOBG2sIIKjPEhl-rbMIdh_IXc0USPOlAEQUUUYkiGXo9Tlv2wBvXTXgLdBsHA25217A4-6WSGCriqCbRZuMAiUysNaUTjJlKFJoFGuJi64tUV6vObRL6GieKXrOA3YFFVDoIWhUtTAmf4yxDL8fuKMLwLqMbv1jHMQxev-qqKDK003PUuAtKIbWY8wyJDV7b2OZmT_P7tIMJF2D8cf70P7b0At3-fDhRH98df3iG7kBP733aRVurs7Xfi_bYyjzvJO4vB10oRA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Defining+the+Syrian+hamster+as+a+highly+susceptible+preclinical+model+for+SARS-CoV-2+infection&rft.jtitle=Emerging+microbes+%26+infections&rft.au=Rosenke%2C+Kyle&rft.au=Meade-White%2C+Kimberly&rft.au=Letko%2C+Michael&rft.au=Clancy%2C+Chad&rft.date=2020-01-01&rft.issn=2222-1751&rft.eissn=2222-1751&rft.volume=9&rft.issue=1&rft.spage=2673&rft.epage=2684&rft_id=info:doi/10.1080%2F22221751.2020.1858177&rft.externalDBID=n%2Fa&rft.externalDocID=10_1080_22221751_2020_1858177
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2222-1751&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2222-1751&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2222-1751&client=summon